Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Prevalence of dry eye in Japanese eye centers. [electronic resource] by
- Hikichi, T
- Yoshida, A
- Fukui, Y
- Hamano, T
- Ri, M
- Araki, K
- Horimoto, K
- Takamura, E
- Kitagawa, K
- Oyama, M
Producer: 19960209
In:
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie vol. 233
Availability: No items available.
|
|
9.
|
The CCR4 as a novel-specific molecular target for immunotherapy in Hodgkin lymphoma. [electronic resource] by
- Ishida, T
- Ishii, T
- Inagaki, A
- Yano, H
- Kusumoto, S
- Ri, M
- Komatsu, H
- Iida, S
- Inagaki, H
- Ueda, R
Producer: 20070920
In:
Leukemia vol. 20
Availability: No items available.
|
|
10.
|
Phytohemagglutinin-induced IL2 mRNA in whole blood can predict bortezomib-induced peripheral neuropathy for multiple myeloma patients. [electronic resource] by
- Watanabe, T
- Mitsuhashi, M
- Sagawa, M
- Ri, M
- Suzuki, K
- Abe, M
- Ohmachi, K
- Nakagawa, Y
- Nakamura, S
- Chosa, M
- Iida, S
- Kizaki, M
Producer: 20131007
In:
Blood cancer journal vol. 3
Availability: No items available.
|
|
11.
|
Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress. [electronic resource] by
- Ri, M
- Iida, S
- Nakashima, T
- Miyazaki, H
- Mori, F
- Ito, A
- Inagaki, A
- Kusumoto, S
- Ishida, T
- Komatsu, H
- Shiotsu, Y
- Ueda, R
Producer: 20100914
In:
Leukemia vol. 24
Availability: No items available.
|
|
12.
|
Potent antitumor effects of bevacizumab in a microenvironment-dependent human lymphoma mouse model. [electronic resource] by
- Mori, F
- Ishida, T
- Ito, A
- Sato, F
- Masaki, A
- Takino, H
- Ri, M
- Kusumoto, S
- Komatsu, H
- Ueda, R
- Inagaki, H
- Iida, S
Producer: 20121002
In:
Blood cancer journal vol. 2
Availability: No items available.
|
|
13.
|
Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing. [electronic resource] by
- Ri, M
- Tashiro, E
- Oikawa, D
- Shinjo, S
- Tokuda, M
- Yokouchi, Y
- Narita, T
- Masaki, A
- Ito, A
- Ding, J
- Kusumoto, S
- Ishida, T
- Komatsu, H
- Shiotsu, Y
- Ueda, R
- Iwawaki, T
- Imoto, M
- Iida, S
Producer: 20121002
In:
Blood cancer journal vol. 2
Availability: No items available.
|
|
14.
|
t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs. [electronic resource] by
- Narita, T
- Inagaki, A
- Kobayashi, T
- Kuroda, Y
- Fukushima, T
- Nezu, M
- Fuchida, S
- Sakai, H
- Sekiguchi, N
- Sugiura, I
- Maeda, Y
- Takamatsu, H
- Tsukamoto, N
- Maruyama, D
- Kubota, Y
- Kojima, M
- Sunami, K
- Ono, T
- Ri, M
- Tobinai, K
- Iida, S
Producer: 20150916
In:
Blood cancer journal vol. 5
Availability: No items available.
|